Aytu Bioscience Inc (NASDAQ:AYTU) had its Buy rating reiterated by Northland Securities

Analyst Ratings For Aytu Bioscience Inc (NASDAQ:AYTU)

Story continues below

Today, Northland Securities reiterated its Buy rating on Aytu Bioscience Inc (NASDAQ:AYTU).

There are 1 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock.

The current consensus rating on Aytu Bioscience Inc (NASDAQ:AYTU) is Buy with a consensus target price of $10.00 per share, a potential 525.00% upside.

Some recent analyst ratings include

  • 3/27/2019-Aytu Bioscience Inc (NASDAQ:AYTU) had its Buy rating reiterated by Northland Securities
  • On 12/21/2018 David A Green, CFO, sold 3,330 with an average share price of $0.81 per share and the total transaction amounting to $2,697.30.
  • On 3/6/2018 David A Green, CFO, bought 66,600 with an average share price of $0.45 per share and the total transaction amounting to $29,970.00.
  • On 3/6/2018 Jarrett Disbrow, COO, bought 226,105 with an average share price of $0.45 per share and the total transaction amounting to $101,747.25.
  • On 1/20/2016 Joshua R Disbrow, CEO, bought 153,846 with an average share price of $0.65 per share and the total transaction amounting to $99,999.90.

Recent Trading Activity for Aytu Bioscience Inc (NASDAQ:AYTU)
Shares of Aytu Bioscience Inc closed the previous trading session at 1,61 +0,0026 0,16 % with 1.55 shares trading hands.

An ad to help with our costs